Hints and tips:
Related Special Reports
...Although payment reporting standards differ between countries, Soriot receives higher pay than totals reported for other European pharmaceutical executives but is paid slightly less than some US peers....
...Curaleaf is the world’s largest cannabis company, with a market capitalisation of C$4.6bn, and its shares have risen 40 per cent in the past year....
...Soriot already earns more than bosses of larger European pharmaceutical companies....
...The British pharmaceutical company is preparing for a vote on its long-serving leader’s pay at the annual meeting on Thursday, including a rise that would take his package to a maximum of £18.7mn....
...He rolls up his sleeves,” said Karen Massey, chief commercial officer at biotech company Argenx, who worked with him at Roche....
...AstraZeneca has acquired oncology biotech Fusion Pharmaceuticals for $2.4bn to build its expertise and challenge Swiss company Novartis in the developing field of a more targeted form of radiotherapy....
...the first pharmaceutical treatment for the underlying disease,” said Emmick....
...It needs further deals to replenish its pharmaceuticals pipeline....
...Shah Capital now owns 6.7 per cent of Novavax, having first bought into the company in the last quarter of 2022....
...“The company’s main biological asset are NHPs used for pre-clinical trials....
...These shifts have led some companies to remove the UK from their supply chains....
...Any rumours that the company is at risk of defaulting are “flatly untrue”, he said....
...Last year, at the height of pricing negotiations, leaders from 16 of the world’s largest generic and biosimilar companies wrote asking for clarity on specific aspects of the deal....
...The company has warned of zero free cash flow for 2023....
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
...Pharmaceutical companies also have a key role to play in providing affordable access to these essential products. The global industry’s response to date has been inadequate and fragmented....
...Ireland’s GDP data, however, come with a caveat: the numbers are regularly skewed by the impact of global companies....
...Shockwave’s technology has treated approximately 400,000 patients globally, the company said....
...The company has been working with the pharmaceutical giant GSK, focusing on immuno-oncology drugs....
...Like many European pharmaceutical companies, it makes a large proportion of sales in the US....
...The US pharmaceutical company — whose shares are up 130 per cent over the past year and is now a top-10 S&P 500 stock — chose the week of the Oscars to launch an advert called “Big Night”....
...But after years of trying, the pharmaceuticals industry is getting to grips with the multibillion-dollar problem of fatty liver disease....
...In February, the UK pharmaceuticals company hit a long-term sales target that once seemed out of reach....
...make up the backbone of pharmaceutical care....
...Novo Nordisk purchased Dicerna Pharmaceuticals, a company focused in RNA-based therapeutics, for $3.3bn in 2021....
International Edition